Treatment and management of myelofibrosis in the era of JAK inhibitors

Clodagh Keohane, Deepti H Radia, Claire N HarrisonDepartment of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UKAbstract: Myelofibrosis (MF) can present as a primary disorder or evolve from polycythemia vera (PV) or essential thrombocythemia (ET) to post-PV MF or po...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keohane C, Radia DH, Harrison CN
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/4f49a0ed1ad64993aad5401da2392057
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!